Form 4 for AXIL Axil Brands, Inc.
Accepted 2024-02-20 00:00:00 ET · period of report 2024-02-14 · accession 0001062993-24-003687 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-20 | 2024-02-14 | AXIL | Ohri Manu | Dir | A - Grant | $0.00 | +5,000 | 5,001 | +500,000% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-14 | A | A | 5,000 | $0.00 | 5,001 | D | — | — | (F1) This restricted stock award was granted under the Reviv3 Procare Company 2022 Equity Incentive Plan in a transaction exempt under Rule 16b-3 and vests on February 14, 2025, except as otherwise provided in the award notice. |